Glia inflammation and cell death pathways drive disease progression in preclinical and early AD
- DOI
- 10.1038/s44321-025-00316-1
- Published
- 2025-10-10
- Container
- EMBO Molecular Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s44321-025-00316-1,
title = {Glia inflammation and cell death pathways drive disease progression in preclinical and early AD},
author = {Marcel S Woo and Joseph Therriault and Seyyed Ali Hosseini and Yi-Ting Wang and Arthur C Macedo and Nesrine Rahmouni and Étienne Aumont and Stijn Servaes and Cécile Tissot and Jaime Fernandez-Arias and Lydia Trudel and Brandon Hall and Gleb Bezgin and Kely Quispialaya-Socualaya and Marina Goncalves and Tevy Chan and Jenna Stevenson and Yansheng Zheng and Stuart Mitchell and Robert Hopewell and Ilaria Pola and Kubra Tan and Guglielmo Di Molfetta and Firoza Z Lussier and Gassan Massarweh and Paolo Vitali and Jean-Paul Soucy and Serge Gauthier and Nicholas J Ashton and Kaj Blennow and Tharick A Pascoal and Henrik Zetterberg and Andréa L Benedet and Pedro Rosa-Neto},
year = {2025},
journal = {EMBO Molecular Medicine},
doi = {10.1038/s44321-025-00316-1},
url = {https://doi.org/10.1038/s44321-025-00316-1}
}RIS
TY - JOUR TI - Glia inflammation and cell death pathways drive disease progression in preclinical and early AD AU - Marcel S Woo AU - Joseph Therriault AU - Seyyed Ali Hosseini AU - Yi-Ting Wang AU - Arthur C Macedo AU - Nesrine Rahmouni AU - Étienne Aumont AU - Stijn Servaes AU - Cécile Tissot AU - Jaime Fernandez-Arias AU - Lydia Trudel AU - Brandon Hall AU - Gleb Bezgin AU - Kely Quispialaya-Socualaya AU - Marina Goncalves AU - Tevy Chan AU - Jenna Stevenson AU - Yansheng Zheng AU - Stuart Mitchell AU - Robert Hopewell AU - Ilaria Pola AU - Kubra Tan AU - Guglielmo Di Molfetta AU - Firoza Z Lussier AU - Gassan Massarweh AU - Paolo Vitali AU - Jean-Paul Soucy AU - Serge Gauthier AU - Nicholas J Ashton AU - Kaj Blennow AU - Tharick A Pascoal AU - Henrik Zetterberg AU - Andréa L Benedet AU - Pedro Rosa-Neto PY - 2025 JO - EMBO Molecular Medicine DO - 10.1038/s44321-025-00316-1 UR - https://doi.org/10.1038/s44321-025-00316-1 ER -
APA
Woo, M. S., Therriault, J., Hosseini, S. A., Wang, Y., Macedo, A. C., Rahmouni, N., Aumont, É., Servaes, S., Tissot, C., Fernandez-Arias, J., Trudel, L., Hall, B., Bezgin, G., Quispialaya-Socualaya, K., Goncalves, M., Chan, T., Stevenson, J., Zheng, Y., Mitchell, S., Hopewell, R., Pola, I., Tan, K., Molfetta, G. D., Lussier, F. Z., Massarweh, G., Vitali, P., Soucy, J., Gauthier, S., Ashton, N. J., Blennow, K., Pascoal, T. A., Zetterberg, H., Benedet, A. L., & Rosa-Neto, P. (2025). Glia inflammation and cell death pathways drive disease progression in preclinical and early AD. EMBO Molecular Medicine. https://doi.org/10.1038/s44321-025-00316-1
Source records
- crossref · retrieved 2026-09-26T00:43:08.135Z